DE60237089D1 - Kompetitiver bindungstest zur identifikation von hcv-polymeraseinhibitoren - Google Patents
Kompetitiver bindungstest zur identifikation von hcv-polymeraseinhibitorenInfo
- Publication number
- DE60237089D1 DE60237089D1 DE60237089T DE60237089T DE60237089D1 DE 60237089 D1 DE60237089 D1 DE 60237089D1 DE 60237089 T DE60237089 T DE 60237089T DE 60237089 T DE60237089 T DE 60237089T DE 60237089 D1 DE60237089 D1 DE 60237089D1
- Authority
- DE
- Germany
- Prior art keywords
- sup
- sub
- alkyl
- hcv polymerase
- het
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/536—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase
- G01N33/542—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase with steric inhibition or signal modification, e.g. fluorescent quenching
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/48—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving transferase
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses
- G01N2333/08—RNA viruses
- G01N2333/18—Togaviridae; Flaviviridae
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/90—Enzymes; Proenzymes
- G01N2333/91—Transferases (2.)
- G01N2333/912—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
- G01N2333/91205—Phosphotransferases in general
- G01N2333/91245—Nucleotidyltransferases (2.7.7)
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2500/00—Screening for compounds of potential therapeutic value
- G01N2500/02—Screening involving studying the effect of compounds C on the interaction between interacting molecules A and B (e.g. A = enzyme and B = substrate for A, or A = receptor and B = ligand for the receptor)
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2500/00—Screening for compounds of potential therapeutic value
- G01N2500/04—Screening involving studying the effect of compounds C directly on molecule A (e.g. C are potential ligands for a receptor A, or potential substrates for an enzyme A)
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Organic Chemistry (AREA)
- Microbiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Biotechnology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Medicinal Chemistry (AREA)
- Food Science & Technology (AREA)
- Cell Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Hydrogenated Pyridines (AREA)
- Peptides Or Proteins (AREA)
- Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Enzymes And Modification Thereof (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US31027201P | 2001-08-07 | 2001-08-07 | |
PCT/CA2002/001214 WO2003014377A2 (en) | 2001-08-07 | 2002-08-05 | Competitive binding assay for identifying inhibitors of hcv polymerase |
Publications (1)
Publication Number | Publication Date |
---|---|
DE60237089D1 true DE60237089D1 (de) | 2010-09-02 |
Family
ID=23201740
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE60237089T Expired - Lifetime DE60237089D1 (de) | 2001-08-07 | 2002-08-05 | Kompetitiver bindungstest zur identifikation von hcv-polymeraseinhibitoren |
Country Status (13)
Country | Link |
---|---|
US (1) | US7294457B2 (de) |
EP (1) | EP1417493B1 (de) |
JP (1) | JP4646514B2 (de) |
AT (1) | ATE475095T1 (de) |
CA (1) | CA2450142C (de) |
DE (1) | DE60237089D1 (de) |
DK (1) | DK1417493T3 (de) |
ES (1) | ES2347954T3 (de) |
HU (1) | HUP0400670A3 (de) |
IL (1) | IL159981A0 (de) |
MX (1) | MXPA04001127A (de) |
NZ (2) | NZ554933A (de) |
WO (1) | WO2003014377A2 (de) |
Families Citing this family (34)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2335700A1 (de) * | 2001-07-25 | 2011-06-22 | Boehringer Ingelheim (Canada) Ltd. | Hepatitis C Virus Polymerase Inhibitoren mit heterobicylischer Struktur |
GB0215293D0 (en) | 2002-07-03 | 2002-08-14 | Rega Foundation | Viral inhibitors |
US7098231B2 (en) * | 2003-01-22 | 2006-08-29 | Boehringer Ingelheim International Gmbh | Viral polymerase inhibitors |
US7223785B2 (en) * | 2003-01-22 | 2007-05-29 | Boehringer Ingelheim International Gmbh | Viral polymerase inhibitors |
US7592352B2 (en) | 2003-05-06 | 2009-09-22 | Smithkline Beecham Corporation | Substituted thieno and furo-pyridines |
US7511145B2 (en) | 2003-08-01 | 2009-03-31 | Genelabs Technologies, Inc. | Bicyclic heteroaryl derivatives |
USRE47600E1 (en) | 2003-11-10 | 2019-09-10 | STATS ChipPAC Pte. Ltd. | Semiconductor device and method of forming electrical interconnect with stress relief void |
US8216930B2 (en) | 2006-12-14 | 2012-07-10 | Stats Chippac, Ltd. | Solder joint flip chip interconnection having relief structure |
WO2005048311A2 (en) | 2003-11-10 | 2005-05-26 | Chippac, Inc. | Bump-on-lead flip chip interconnection |
US8574959B2 (en) | 2003-11-10 | 2013-11-05 | Stats Chippac, Ltd. | Semiconductor device and method of forming bump-on-lead interconnection |
US9029196B2 (en) | 2003-11-10 | 2015-05-12 | Stats Chippac, Ltd. | Semiconductor device and method of self-confinement of conductive bump material during reflow without solder mask |
US8026128B2 (en) | 2004-11-10 | 2011-09-27 | Stats Chippac, Ltd. | Semiconductor device and method of self-confinement of conductive bump material during reflow without solder mask |
US8129841B2 (en) | 2006-12-14 | 2012-03-06 | Stats Chippac, Ltd. | Solder joint flip chip interconnection |
EP1688420A4 (de) * | 2003-11-19 | 2008-10-22 | Japan Tobacco Inc | 5-5-gliedrige kondensierte heterocyclische verbindung und deren verwendung als hcv-polymeraseinhibitor |
PL1706403T3 (pl) * | 2003-12-22 | 2012-07-31 | K U Leuven Res & Development | Związki imidazo[4,5-c]pirydynowe i sposoby leczenia przeciwwirusowego |
KR20120091276A (ko) * | 2004-02-20 | 2012-08-17 | 베링거 인겔하임 인터내셔날 게엠베하 | 바이러스 폴리머라제 억제제 |
US20070049593A1 (en) | 2004-02-24 | 2007-03-01 | Japan Tobacco Inc. | Tetracyclic fused heterocyclic compound and use thereof as HCV polymerase inhibitor |
ATE428714T1 (de) * | 2004-02-24 | 2009-05-15 | Japan Tobacco Inc | Kondensierte heterotetracyclische verbindungen und deren verwendung als hcv-polymerase-inhibitor |
BRPI0511834A (pt) * | 2004-07-14 | 2008-01-08 | Ptc Therapeutics Inc | métodos por tratar hepatite c |
DE602005013580D1 (de) * | 2004-12-21 | 2009-05-07 | Leuven K U Res & Dev | Imidazoä4,5-cüpyridinverbindung und verfahren zur antiviralen behandlung |
US8703795B2 (en) | 2005-03-02 | 2014-04-22 | Fibrogen, Inc. | Thienopyridine compounds, and methods of use thereof |
JP2008535225A (ja) | 2005-03-25 | 2008-08-28 | スタッツ チップパック リミテッド | 基板上に狭い配線部分を有するフリップチップ配線 |
US8841779B2 (en) | 2005-03-25 | 2014-09-23 | Stats Chippac, Ltd. | Semiconductor device and method of forming high routing density BOL BONL and BONP interconnect sites on substrate |
CA2618682C (en) * | 2005-08-12 | 2011-06-21 | Boehringer Ingelheim International Gmbh | Viral polymerase inhibitors |
EP2044028B1 (de) | 2006-01-27 | 2012-05-16 | Fibrogen, Inc. | Cyanoisochinoline zur stabilisierung des hypoxie-induzierten faktors (hif) |
WO2007115315A2 (en) * | 2006-04-04 | 2007-10-11 | Fibrogen, Inc. | Pyrrolo- and thiazolo-pyridine compounds as hif modulators |
TWI360549B (en) * | 2006-07-07 | 2012-03-21 | Gilead Sciences Inc | Novel pyridazine compound and use thereof |
UA99466C2 (en) | 2007-07-06 | 2012-08-27 | Гилиад Сайенсиз, Инк. | Crystalline pyridazine compound |
WO2010056767A1 (en) | 2008-11-14 | 2010-05-20 | Fibrogen, Inc. | Thiochromene derivatives as hip hydroxylase inhibitors |
RU2015114772A (ru) | 2012-09-21 | 2016-11-10 | Санофи | Производные амида бензоимидазол-карбоновой кислоты в качестве модуляторов рецептора apj |
AU2014209319B2 (en) | 2013-01-24 | 2018-04-19 | Fibrogen, Inc. | Crystalline forms of {[1-cyano-5-(4-chlorophenoxy)-4-hydroxy-isoquinoline-3-carbonyl]-amino}-acetic acid |
CR20180413A (es) | 2016-02-05 | 2018-12-04 | Denali Therapeutics Inc | Inhibidores de la proteína quinasa 1 que interactua con el receptor |
WO2018107060A1 (en) | 2016-12-09 | 2018-06-14 | Denali Therapeutics Inc. | Compounds, compositions and methods |
TW202334089A (zh) | 2021-11-02 | 2023-09-01 | 美商夫雷爾醫療公司 | Pparg反向激動劑及其用途 |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2334161A1 (en) * | 1998-07-20 | 2000-01-27 | Ribozyme Pharmaceuticals, Inc. | Use of nucleic acid molecules as antiviral agents |
JP2001069995A (ja) * | 1999-07-02 | 2001-03-21 | Japan Tobacco Inc | 結晶構造解析に適したhcvポリメラーゼ及びその利用方法 |
US6770666B2 (en) * | 1999-12-27 | 2004-08-03 | Japan Tobacco Inc. | Fused-ring compounds and use thereof as drugs |
CA2363274A1 (en) | 1999-12-27 | 2001-07-05 | Japan Tobacco Inc. | Fused-ring compounds and use thereof as drugs for hepatitis c |
US6448281B1 (en) * | 2000-07-06 | 2002-09-10 | Boehringer Ingelheim (Canada) Ltd. | Viral polymerase inhibitors |
JP2004520839A (ja) | 2001-03-08 | 2004-07-15 | ベーリンガー インゲルハイム (カナダ) リミテッド | Hcvのrna依存性rnaポリメラーゼ(ns5b)の阻害剤を同定するための分析法 |
WO2003007945A1 (en) | 2001-07-20 | 2003-01-30 | Boehringer Ingelheim (Canada) Ltd. | Viral polymerase inhibitors |
EP2335700A1 (de) | 2001-07-25 | 2011-06-22 | Boehringer Ingelheim (Canada) Ltd. | Hepatitis C Virus Polymerase Inhibitoren mit heterobicylischer Struktur |
-
2002
- 2002-08-02 US US10/211,455 patent/US7294457B2/en active Active
- 2002-08-05 WO PCT/CA2002/001214 patent/WO2003014377A2/en active Application Filing
- 2002-08-05 NZ NZ554933A patent/NZ554933A/en not_active IP Right Cessation
- 2002-08-05 MX MXPA04001127A patent/MXPA04001127A/es active IP Right Grant
- 2002-08-05 AT AT02753998T patent/ATE475095T1/de active
- 2002-08-05 DE DE60237089T patent/DE60237089D1/de not_active Expired - Lifetime
- 2002-08-05 JP JP2003519506A patent/JP4646514B2/ja not_active Expired - Fee Related
- 2002-08-05 EP EP02753998A patent/EP1417493B1/de not_active Expired - Lifetime
- 2002-08-05 ES ES02753998T patent/ES2347954T3/es not_active Expired - Lifetime
- 2002-08-05 IL IL15998102A patent/IL159981A0/xx not_active IP Right Cessation
- 2002-08-05 CA CA002450142A patent/CA2450142C/en not_active Expired - Fee Related
- 2002-08-05 DK DK02753998.0T patent/DK1417493T3/da active
- 2002-08-05 NZ NZ531488A patent/NZ531488A/en not_active IP Right Cessation
- 2002-08-05 HU HU0400670A patent/HUP0400670A3/hu unknown
Also Published As
Publication number | Publication date |
---|---|
NZ554933A (en) | 2009-01-31 |
HUP0400670A3 (en) | 2006-06-28 |
IL159981A0 (en) | 2004-06-20 |
JP2005500055A (ja) | 2005-01-06 |
EP1417493B1 (de) | 2010-07-21 |
US20030108862A1 (en) | 2003-06-12 |
ATE475095T1 (de) | 2010-08-15 |
ES2347954T3 (es) | 2010-11-26 |
DK1417493T3 (da) | 2010-10-04 |
NZ531488A (en) | 2008-06-30 |
WO2003014377A2 (en) | 2003-02-20 |
MXPA04001127A (es) | 2004-07-08 |
US7294457B2 (en) | 2007-11-13 |
CA2450142A1 (en) | 2003-02-20 |
EP1417493A2 (de) | 2004-05-12 |
CA2450142C (en) | 2009-12-22 |
HUP0400670A2 (en) | 2006-03-28 |
WO2003014377A3 (en) | 2003-12-18 |
JP4646514B2 (ja) | 2011-03-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE60237089D1 (de) | Kompetitiver bindungstest zur identifikation von hcv-polymeraseinhibitoren | |
DE60334524D1 (de) | E2-verdrängungs-assay zur identifizierung von hpv-inhibitoren | |
DK1414797T3 (da) | Hepatitis C-viruspolymeraseinhibitorer med en heterobicyklisk struktur | |
ATE556323T1 (de) | Neurofibrilläre marker | |
TNSN04163A1 (fr) | N-aryl-2-oxazolidinone-5-carboxamides et leurs derives et leur utilisation comme agents antibacteriens | |
DE602005023529D1 (de) | Homogener nachweis von analyten | |
WO2006128138A3 (en) | Biodetection by nucleic acid-templated chemistry | |
DE60020584D1 (de) | Verbindungen zur floureszenz-kennzeichnung | |
ATE342896T1 (de) | Fluoreszierende proben zur quantitativen bestimmung von zink | |
ATE437965T1 (de) | Doppelsträngige sonden zur fluoreszenzdetektion von nukleinsäuren | |
DE50209786D1 (de) | 7-aminotriazolopyrimidine zur bekämpfung von schadpilzen | |
DE69507028D1 (de) | Verfahren und zusammensetzungen zur kontrolle der reaktivität zwischen diagnostischen reagenzien und mikroorganismen | |
ATE258598T1 (de) | Verfahren zur proteinrückfaltung durch verwendung zwitterionischer wirkstoffe von niedrigem molekulargewicht | |
ATE542917T1 (de) | Zusammensetzungen, verfahren und kits zur bestimmung des vorhandenseins von trichomonas vaginalis in einer testprobe | |
ATE501120T1 (de) | Verfahren zur herstellung von isoindolderivaten | |
ATE333522T1 (de) | Verfahren zur bestimmung von mehrere analyten | |
DE60331422D1 (de) | Fluoreszierendes protein aus aequorea coerulescens und ihre verwendungen | |
DE602004017884D1 (de) | Fluoreszenzsonden zur verwendung bei einem bindungsassay auf proteinkinaseinhibitoren | |
FI924713A (fi) | Foerfarande foer saollning av proteinpartner och anvaendning av dessa | |
BR0013075A (pt) | Derivados de tetrazolinona | |
HUP0300154A2 (en) | Method for the production of spirocyclic tetronic acid derivatives | |
ATE500505T1 (de) | Enzymhemmungsimmunverfahren | |
DE602004010530D1 (de) | Verfahren zur herstellung von phenyltetrazolderivaten | |
DE602004026110D1 (de) | Verfahren zur inhibierung der verfärbung von methylenbisanilinverbindungen | |
PL428082A1 (pl) | Sposób syntezy pochodnych pirydyn-2-yl-winylopirydynylowych (PvP) |